• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

PTC to sell spinal muscular atrophy drug royalties for $1B

cafead

Administrator
Staff member
  • cafead   Oct 19, 2023 at 11:52: AM
via
  • PTC Therapeutics has agreed to sell a big chunk of its remaining royalty stream from the spinal muscular atrophy drug Evrysdi to Royalty Pharma for $1 billion.

article source
 

<